CAVALLI, F.M.G., M. REMKE, L. RAMPASEK, J. PEACOCK, D.J.H. SHIH, B. LUU, L. GARZIA, J. TORCHIA, C. NOR, A.S. MORRISSY, S. AGNIHOTRI, Y.Y. THOMPSON, C.M. KUZAN-FISCHER, H. FAROOQ, K. ISAEV, C. DANIELS, B.K. CHO, S.K. KIM, K.C. WANG, J.Y. LEE, W.A. GRAJKOWSKA, M. PEREK-POLNIK, A. VASILJEVIC, C. FAURE-CONTER, A. JOUVET, C. GIANNINI, A.A.N. RAO, K.K.W. LI, H.K. NG, C.G. EBERHART, I.F. POLLACK, R.L. HAMILTON, G.Y. GILLESPIE, J.M. OLSON, S. LEARY, W.A. WEISS, B. LACH, L.B. CHAMBLESS, R.C. THOMPSON, M.K. COOPER, R. VIBHAKAR, P. HAUSER, M.L.C. van VEELEN, J.M. KROS, P.J. FRENCH, Y.S. RA, T. KUMABE, E. LOPEZ-AGUILAR, Karel ZITTERBART, Jaroslav ŠTĚRBA, G. FINOCCHIARO, M. MASSIMINO, E.G. VAN MEIR, S. OSUKA, T. SHOFUDA, A. KLEKNER, M. ZOLLO, J.R. LEONARD, J.B. RUBIN, N. JABADO, S. ALBRECHT, J. MORA, T.E. VAN METER, S. JUNG, A.S. MOORE, A.R. HALLAHAN, J.A. CHAN, D.C. TIRAPELI, C.G. CARLOTTO, M. FOULADI, J. PIMENTEL, C.C. FARIA, A.G. SAAD, L. MASSIMI, L.M. LIAU, H. WHEELER, H. NAKAMURA, S.K. ELBABAA, M. PEREZPENA DIAZCONTI, F.C. PONCE DE LEÓN, S. ROBINSON, M. ZAPOTOCKY, A. LASSALETTA, A. HUANG, C.E. HAWKINS, U. TABORI, E. BOUFFET, U. BARTELS, P.B. DIRKS, J.T. RUTKA, G.D. BADER, J. REIMAND, A. GOLDENBERG, V. RAMASWAMY and M.D. TAYLOR. Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. Cambridge: Cell Press, 2017, vol. 31, No 6, p. "737"-"+", 24 pp. ISSN 1535-6108. Available from: https://dx.doi.org/10.1016/j.ccell.2017.05.005.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Intertumoral Heterogeneity within Medulloblastoma Subgroups
Authors CAVALLI, F.M.G. (124 Canada), M. REMKE (124 Canada), L. RAMPASEK (124 Canada), J. PEACOCK (124 Canada), D.J.H. SHIH (124 Canada), B. LUU (124 Canada), L. GARZIA (124 Canada), J. TORCHIA (124 Canada), C. NOR (124 Canada), A.S. MORRISSY (124 Canada), S. AGNIHOTRI (840 United States of America), Y.Y. THOMPSON (124 Canada), C.M. KUZAN-FISCHER (124 Canada), H. FAROOQ (124 Canada), K. ISAEV (124 Canada), C. DANIELS (124 Canada), B.K. CHO (410 Republic of Korea), S.K. KIM (410 Republic of Korea), K.C. WANG (410 Republic of Korea), J.Y. LEE (410 Republic of Korea), W.A. GRAJKOWSKA (840 United States of America), M. PEREK-POLNIK (616 Poland), A. VASILJEVIC (250 France), C. FAURE-CONTER (250 France), A. JOUVET (250 France), C. GIANNINI (840 United States of America), A.A.N. RAO (840 United States of America), K.K.W. LI (156 China), H.K. NG (156 China), C.G. EBERHART (840 United States of America), I.F. POLLACK (840 United States of America), R.L. HAMILTON (840 United States of America), G.Y. GILLESPIE (840 United States of America), J.M. OLSON (840 United States of America), S. LEARY (840 United States of America), W.A. WEISS (840 United States of America), B. LACH (124 Canada), L.B. CHAMBLESS (840 United States of America), R.C. THOMPSON (840 United States of America), M.K. COOPER (840 United States of America), R. VIBHAKAR (840 United States of America), P. HAUSER (348 Hungary), M.L.C. van VEELEN (528 Netherlands), J.M. KROS (528 Netherlands), P.J. FRENCH (528 Netherlands), Y.S. RA (410 Republic of Korea), T. KUMABE (392 Japan), E. LOPEZ-AGUILAR (484 Mexico), Karel ZITTERBART (203 Czech Republic, belonging to the institution), Jaroslav ŠTĚRBA (203 Czech Republic, guarantor, belonging to the institution), G. FINOCCHIARO (380 Italy), M. MASSIMINO (380 Italy), E.G. VAN MEIR (840 United States of America), S. OSUKA (840 United States of America), T. SHOFUDA (392 Japan), A. KLEKNER (348 Hungary), M. ZOLLO (380 Italy), J.R. LEONARD (840 United States of America), J.B. RUBIN (840 United States of America), N. JABADO (124 Canada), S. ALBRECHT (124 Canada), J. MORA (724 Spain), T.E. VAN METER (840 United States of America), S. JUNG (410 Republic of Korea), A.S. MOORE (36 Australia), A.R. HALLAHAN (36 Australia), J.A. CHAN (124 Canada), D.C. TIRAPELI (76 Brazil), C.G. CARLOTTO (76 Brazil), M. FOULADI (840 United States of America), J. PIMENTEL (620 Portugal), C.C. FARIA (620 Portugal), A.G. SAAD (840 United States of America), L. MASSIMI (380 Italy), L.M. LIAU (840 United States of America), H. WHEELER (36 Australia), H. NAKAMURA (392 Japan), S.K. ELBABAA (840 United States of America), M. PEREZPENA DIAZCONTI (484 Mexico), F.C. PONCE DE LEÓN (484 Mexico), S. ROBINSON (840 United States of America), M. ZAPOTOCKY (124 Canada), A. LASSALETTA (124 Canada), A. HUANG (124 Canada), C.E. HAWKINS (124 Canada), U. TABORI (124 Canada), E. BOUFFET (124 Canada), U. BARTELS (124 Canada), P.B. DIRKS (124 Canada), J.T. RUTKA (124 Canada), G.D. BADER (124 Canada), J. REIMAND (124 Canada), A. GOLDENBERG (124 Canada), V. RAMASWAMY (124 Canada) and M.D. TAYLOR (124 Canada).
Edition Cancer Cell, Cambridge, Cell Press, 2017, 1535-6108.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 22.844
RIV identification code RIV/00216224:14110/17:00098842
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.ccell.2017.05.005
UT WoS 000403074800005
Keywords in English Intertumoral Heterogeneity
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 15:07.
Abstract
While molecular subgrouping has revolutionized medulloblastoma classification, the extent of heterogeneity within subgroups is unknown. Similarity network fusion (SNF) applied to genome-wide DNA methylation and gene expression data across 763 primary samples identifies very homogeneous clusters of patients, supporting the presence of medulloblastoma subtypes. After integration of somatic copy-number alterations, and clinical features specific to each cluster, we identify 12 different subtypes of medulloblastoma. Integrative analysis using SNF further delineates group 3 from group 4 medulloblastoma, which is not as readily apparent through analyses of individual data types. Two clear subtypes of infants with Sonic Hedgehog medulloblastoma with disparate outcomes and biology are identified. Medulloblastoma subtypes identified through integrative clustering have important implications for stratification of future clinical trials.
Links
EE2.3.20.0183, research and development projectName: Centrum experimentální biomedicíny
PrintDisplayed: 14/5/2024 11:57